hypertriglyceridemia, have been found to be associated with lower circulating NP concentrations. [3] [4] [5] [6] [7] [8] [9] Besides renal and vascular effects, the NPs are also involved in the regulation of lipolysis and lipid oxidation, and therefore it has been proposed that there is an important cardio-metabolic crosstalk between the endocrine heart, adipose tissue, and muscle, and that this cross-talk could be disrupted in overweight-related diseases. 3, 4 Little is known about circulating NP concentrations in relation to anthropometric and metabolic parameters as well as BP in healthy adolescents and young adults (<30 years old) from the general population, although such relationships have been widely studied in community-based middleaged and elderly persons (>40 years old). [5] [6] [7] 9 Therefore, we studied a large sample of adolescents and young adults from the Danish site of the European Youth Heart Study (EYHS), which is an international population-based study of cardiovascular disease (CVD) risk factors in children, adolescents, and young adults. 10, 11 The EYHS includes standardised BP measurements, anthropometric measurements, such as BMI and WC, measurements of lipids, insulin and glucose, and a bio-bank, enabling us to measure plasma concentrations of mid-regional proatrial NP (MR-proANP), as stable marker of ANP secretion. 12 
METHODS

Study population
This study is a cross-sectional study using Danish EYHS data. 11 A detailed description of the EYHS protocol has been reported elsewhere. 10 In 2009-2010, random samples of 709 14-16 year-old healthy adolescents, 469 20-22 yearold healthy adults, and 658 26-28 year-old healthy adults were invited to take part in the Danish part of the study. The participation rate was 59% (n = 399) for the adolescents and 46% (n = 650) for the young adults. Exclusion criteria were pregnancy (n = 12), diabetes (n = 3) and nonfasting (n = 32), leaving 959 individuals for the study. In the case of missing data, these were handled with the pairwise deletion technique, which involves deleting a case when it is missing a variable required for a particular analysis, but including that case in analyses for which all required variables are present. Because of this, total number varies in the various models. In analyses assessing IR, expressed by the Homeostatic Model Assessment 2 for IR (HOMA2-IR), 13 we excluded, as prescribed, individuals with fasting glucose concentrations outside the range of 3.5-25.0 mmol/L and with fasting insulin concentrations outside the range of 20-400 pmol/L (n = 3 glucose < 3.5 mmol/L, n = 0 glucose > 25.0 mmol/L, n = 83 insulin < 20 pmol/L, and n = 2 insulin > 400 pmol/L), leaving 873 individuals for the IR analyses. We performed age-group stratified analyses because this enabled us to identify changes in the strength of the various associations with increasing age. The study was approved by the Regional Scientific Ethical Committee for Southern Denmark, and data was collected according to the Declaration of Helsinki. All participants gave their written informed consent.
Anthropometry and maturity
Weight, height, and WC were measured while the participants were wearing light clothing, without shoes. WC was measured midway between the lower rib margin and the iliac crest at the end of gentle expiration. BMI was calculated as weight (kg)/square of height (m 2 ). Pubertal status was assessed according to Tanner, 14 as described elsewhere. 15 Maturity stage among the adolescents was almost exclusively stage 3, 4 and 5, thus, we collapsed maturity to a 3-point ordinal variable (Tanner 2-3, Tanner 4, and Tanner 5).
Blood measurements
Venous blood samples were drawn in the morning after at least 8 h of fasting. Plasma concentrations of MR-proANP were measured with a commercially available sandwich chemiluminescence immunoassay (Thermo-Fisher, MA) with intra-assay and inter-assay coefficients of variation below 2% and 6%, respectively, and a lower detection limit of 4.5 pmol/L. Glucose, total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride concentrations were measured using a Olympus AU600 random access analyser. Insulin was analysed using an enzyme immunoassay (Dako Diagnostics, Ely, UK).
BP measurements
BP was measured with participants in the upright sitting position after resting for 5 min, using a Dinamap monitor (Dinamap model XL-Kivex/Critikron, Tampa, FL). Five measurements were conducted with 2 min intervals between each, and the mean of the last three measurements was used. The Dinamap monitor has previously been validated in children and adolescents against direct radial artery readings (mean error 0.24 mm Hg systolic (S) BP and 1.28 mm Hg diastolic (D) BP). 16 
Statistical analysis
All statistical analyses were performed in STATA 13.0 (STATA Corporation, College Station, TX). Normally distributed continuous data are presented as mean ± standard deviation (SD) and non-normally distributed continuous data as median (interquartile range). Categorical data are presented as frequency percent. Group comparisons were performed using t-test for continuous data and chi-squared test for categorical data. To fulfil the model assumptions of the t-test, non-normally distributed variables (MR-proANP, triglycerides, insulin, and HOMA2-IR) had to be log-transformed prior to group comparisons. Multivariable linear regression was used to examine the associations, expressed as standardized regression coefficients, of various variables of interest with MR-proANP stratified according to age group, adjusting for age and gender. In the regression models, nonnormally distributed variables (MR-proANP, triglycerides, insulin, and HOMA2-IR) had to be log-transformed to fulfil the model assumptions of linear regression. Furthermore, we specifically examined age-group dependent relationships between MR-proANP and components of the MS by testing interactions. All statistical tests were 2-sided, and a P-value <0.05 was considered significant.
RESULTS
General characteristics of the participants are presented in Table 1 . A few of these results have been published previously in an article reporting the effect of gender and pubertal stage on circulating MR-proANP concentrations in adolescents. 15 As expected, our participants had overall normal BP and lipids levels.
Among the adolescents, males were significantly older, heavier, and taller compared with females (P < 0.01), but there were no significant gender differences in BMI and WC (P > 0.09). Males had higher SBP but lower DBP compared with females, and they had lower LDL-C (P < 0.01). Regarding metabolic variables, males had higher glucose concentrations, but, despite higher SBP, they had lower plasma concentrations of MR-proANP (36.4 pmol/L (30.4-44.7) vs. 42.2 pmol/L (32.0-50.2), P < 0.01), whereas there were no significant gender differences in insulin concentrations and HOMA2-IR (P > 0.13).
In the adult group, males were taller, heavier, had higher BMI and larger WC compared with females (P < 0.01). They had higher SBP and DBP, and they had lower HDL-C (P < 0.01). Concerning metabolic variables, males had higher glucose concentrations (P < 0.01) but lower insulin concentrations (P < 0.01) and lower degree of IR (P < 0.05), and, despite higher SBP, they had lower plasma concentrations of MR-proANP (41.5 pmol/L (32.9-53.0) vs. 52.5 pmol/L (43.1-67.7), P < 0.01).
With respect to gender differences between age groups, adult females were heavier, had higher BMI and larger WC compared with adolescent females (P < 0.05). They also had higher DBP, but not higher SBP, and they had higher lipid concentrations (P < 0.05). Regarding metabolic variables, the adult females had higher glucose concentrations and higher plasma concentrations of MR-proANP but lower insulin concentrations and lower degree of IR compared with adolescent females (P < 0.05). Regarding differences between adolescent males and adult males, adult males were taller, heavier, had higher BMI and larger WC (P < 0.05). They had higher BP and higher triglyceride and LDL-C concentrations (P < 0.05). Regard metabolic variables, adult males had higher glucose concentrations and higher plasma concentrations of MR-proANP, but lower insulin concentrations and degree of IR (P < 0.05). Table 2 and Figure 1 summarize linear regressionbased associations of plasma MR-proANP with variables of interest. Among the adolescents, all anthropometric, hemodynamic, lipid (except for HDL-C), and metabolic variables were negatively associated with MR-proANP, but the strength of the associations only reached statistical significance regarding triglycerides and DBP (P < 0.04). Nevertheless, the strength of the association between SBP and MR-proANP was borderline significant (P = 0.10). Among the adults, all anthropometric, hemodynamic, lipid (except for HDL-C), and metabolic variables were negatively associated with MR-proANP, and the strength of the associations reached statistical significance for all variables except for glucose (P = 0.16). Numerically, 9 of the 10 variables showed stronger associations among the adults compared with the adolescents, and for BMI, WC, DBP, and HDL-C, the strength of the associations were statistically significant different between the age groups, as reflected by a P <0.05 in the interaction analyses.
Finally, associations of SBP and DBP with variables of interest are displayed in Tables 3 and 4 to document that the expected associations between anthropometric and metabolic variables and BP were also found in our study population.
Sensitivity analysis
Adjusting for Tanner stage did not materially change any of the relationships with MR-proANP among the adolescents (data not shown).
DISCUSSION
This study is the first to have measured plasma MR-proANP in a large sample of adolescents and young adults from the general population. Among the adolescents, the well-described negative relationships between the NPs and BMI, WC, insulin and estimates of IR seen later in life were not present. [3] [4] [5] [6] [7] [8] [9] In contrast, among the young adults, all these well-described relationships were present. The only significant metabolic relationship found among the adolescents was a negative relationship between plasma MR-proANP and triglycerides. This relationship was also present in the young adults in whom plasma MR-proANP was also positively associated with HDL-C. Furthermore, we found that in both study groups, plasma MR-proANP was negatively associated with DBP and in the adult study group also with SBP. Finally, based on our interaction analyses, the strength of the relationships between MR-proANP and BMI, WC and DBP were significantly stronger among the young adults compared with the adolescents. Thus our study, although cross-sectional, may provide some understanding about changes in circulating NP concentrations with changes in anthropometry and BP over time.
NPs in children and adolescents
Several smaller studies (n < 150), almost all hospitalbased, [17] [18] [19] [20] [21] [22] [23] have studied the relationships between NPs and anthropometry, metabolism and BP in children and adolescents. The studies are heterogeneous with conflicting results. Most studies measured proBNP-related peptides which in non-cardiac patients circulate in much lower concentrations All data are standardized regression coefficients with 95% confidence intervals, adjusted for age and gender. Abbreviations: BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA2-IR, homeostasis model assessment 2 of insulin resistance; MR-proANP, mid-regional proatrial natriuretic peptide.
than that of proANP-related peptides, thus making it difficult to obtain accurate and reliable information on decreased concentrations. 12 In a Greek study from an obesity clinic, involving 47 girls and 49 boys, aged 10-16 years, without cardiac, hepatic, and renal diseases, plasma NT-proBNP concentrations did not correlate with BMI neither in girls nor in boys, although the obese boys, despite higher SBP (119.7 ± 19.1 vs. 106.5 ± 13.1 mm Hg, P < 0.001), had nonsignificantly lower plasma NT-proBNP concentrations (31.4 8 ± 14.3 pg/mL vs. 46.9 8 ± 33.9 pg/mL) compared with the normal weight boys. 17 Furthermore, plasma NT-proBNP concentrations did not correlate with SBP and DBP, although among the obese boys plasma NT-proBNP concentrations correlated with SBP (r = 0.45, P = 0.03). 17 In a second report from the same population, 18 focusing further on metabolism, plasma NT-proBNP concentrations correlated negatively with HDL-C (r = −0.36, P = 0.03) in boys, whereas no significant correlations were found between plasma NT-proBNP and glucose, insulin, HOMA-IR, cholesterol, and triglycerides.
In an Italian study, hospital-based, 29 obese adolescents without cardiac dysfunction, mean age 11.8 ± 0.4 years, mean BMI 29.8 ± 0.82 kg/m 2 , were found to have lower plasma BNP concentrations (18.8 ± 2.6 vs. 36.9 ± 5.5 pg/ mL, P = 0.003) compared with reference values specific for Italian children and adolescents. 19 In that study, no information regarding BNP and BP were provided, but among the 29 obese adolescents BNP was reported to correlated with glycaemia (r = 0.33, P < 0.05), HDL-C (r = 0.4, P = 0.029) and triglycerides (r = 0.5, P = 0.005). However, in another Italian study from the same group, also hospital-based, involving 82 children and adolescents, mean age 12.8 ± 2.4 years, of whom 27 were normal weight, 10 overweight, and 45 obese, no significant differences were found in circulating concentrations of NT-proBNP or MR-proANP among the three groups. Also in that study, no BP data was provided. 20 In a Turkish study, hospital-based, including 50 obese children and 20 age-and sex-matched healthy normal weight control children, mean age around 10 years, the obese children had significantly higher plasma NT-proBNP concentrations (109.25 ± 48.53 vs. 51.96 ± 22.36 pg/mL, P = 0.001) compared with the normal weight children. 21 In this study, plasma NT-proBNP concentrations were not associated with BP, although the obese children had higher SBP and DBP compared with the normal weight children. 21 In another Turkish study, also hospital-based, involving 68 obese children and 35 healthy controls matched for age and sex, no significant difference was found in plasma NT-proBNP concentrations (56.9 ± 32.9 vs. 53 ± 40.1 pg/mL, P = 0.46) between the two groups, although the obese children had significantly higher SBP (120 ± 15 vs. 106 ± 9 mm Hg, P = 0.001). 22 Furthermore, no differences were found in plasma NT-proBNP concentrations when the participants was subdivided according to presence of the MS, hypertension or IR.
In a Chinese study, involving 114 children and adolescents, 32% females, with a median age of 10.8 years, who were enrolled because of habitual snoring and symptoms suggestive of obstructive sleep apnoea, stepwise multiple regression analysis identified BMI z-score as the only factor significantly (and negatively) associated with ANP and BNP. 23 In this context, it is worth noting that the Chinese children and adolescents, who based on z-score were defined to be obese, had higher BP and lower plasma concentrations of ANP and BNP compared with the nonobese Chinese children and adolescents. 23 Among 138 children and adolescents, age 5-17 years, 55% females, recruited as part of a population-based genetic study Figure 1 . Multivariable linear regression-based associations of serum of mid-regional proatrial natriuretic peptide with variables of interest stratified by age group. Data, which are adjusted for age and sex, are standardized regression coefficients with 95% confidence intervals.
• denotes adolescents and ∎ denotes young adults. Abbreviations: BMI, body mass index; WC, waist circumference; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HOMA2-IR, homeostasis model assessment 2 of insulin resistance.
in southern Italy, BMI was not associated with NT-proBNP (r = 0.003, P = 0.97) in univariate analysis, whereas WC was (r = −0.30, P < 0.001). 24 In that study, no BP measurements were reported, and after adjustment for age, only age was associated with NT-proBNP. 24 
NPs and metabolism
It is interesting to note that the associations reported in the medical literature between circulating NP concentrations and metabolic variables could indeed reflect causal relationships. [3] [4] [5] [6] [7] [8] [9] Thus, in addition to physiological studies supporting some of these relationships, 3, 4 an ANP variant (rs5068) that is associated with higher circulating concentrations of NT-proANP has also been shown to be associated with a lower risk of the MS, 25 and a drug (LCZ696) that increases circulating ANP concentrations through neprilysin inhibition improves insulin sensitivity. 26 
NPs and BP
The relationship between circulating NP concentrations and BP is complex and nonlinear. It is well-established that hypertensive patients with severe hypertension and signs of hypertensive heart disease with enlargement of the left ventricle or the left atrium have increased circulating concentrations of NPs. [27] [28] [29] [30] [31] [32] However, several studies, 33 including genetic studies, 34, 35 have shown that NPs in the high normal range are associated with lower BP and lower risk of hypertension. Our data confirms this observation. Thus, in our healthy adolescents and young adults from the general population, higher circulating MR-proANP concentrations were associated with lower BP. This suggests that a low amount of All data are standardized regression coefficients with 95% confidence intervals, adjusted for age and gender. Abbreviations: BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA2-IR, homeostasis model assessment 2 of insulin resistance; MR-proANP, mid-regional proatrial natriuretic peptide. circulating NPs could play a role in the early stages of hypertension development. [36] [37] [38] 
NP and age
In this study, the young adults had higher circulating MR-proANP concentrations compared with the adolescents. In this context, it is worthy of note that a study from the Framingham Heart study, consisting of a healthy reference sample of 911 subjects (mean age 55 years, 62% women) who were free of hypertension, valvular disease, diabetes, atrial fibrillation, obesity, coronary heart disease, congestive heart failure, and renal failure, and who had normal left ventricular systolic function, showed that the strongest predictors of higher NP concentrations were older age and female sex. 39 Why our young adults had higher circulating MR-proANP concentrations is not exactly clear, because between the two age groups, significant differences were found both in factors expected to be associated with lower and higher circulating NP concentrations, respectively. Thus, the young adults had higher BMI, larger WC, and hypertriglyceridemia, factors expected to be associated with lower circulating NP concentrations, but they also had lower insulin levels and lower degree of IR, elements expected to be associated with higher circulating NP concentrations.
Strengths and limitations
The strengths of this study are its large sample size (although the participation rate was modest), its community-based nature and its measurement of a proANPrelated peptide, because in the normal heart, it is predominantly ANP not BNP that is released in response to normal physiological stimuli. 12 However, it is a limitation that we did not measure intact biologically active ANP, because variability in ANP clearance through the NP receptor-C (NPR-C) or neprilysin cannot be captured by only measuring proANP-related peptides. 4 It is a further limitation that we have no measurements of factors, for example, sodium intake and visceral fat, that could have affected our MR-proANP results. 1, 2, 40 It is also a limitation that the study was cross-sectional and follow-up data could have provided the possibility to better investigate the temporal relationship of MR-proANP with components of the MS and to further examine the effect of age on MR-proANP concentrations in healthy young individuals. Finally, the sample size was smaller for teenagers, which could explain that the associations between MR-proANP and some outcomes were not significant because of lower statistical power.
CONCLUSIONS
Among healthy young adults from the general population, we found basically the same relationships between a NP-related peptide and anthropometry, metabolism and BP as found in other studies including community-based middle-aged and elderly persons.. [3] [4] [5] [6] [7] [8] [9] 39, 40 However, among healthy adolescents from the general population, we only found relationships between a NR-related peptide and triglycerides and DBP. Nevertheless, our results support the view that lower circulating concentrations of NPs could play a role in the early stages of hypertension development. Prospective studies are needed to track changes in circulating NP concentrations with changes in anthropometry, metabolism, and BP from childhood to adolescents and from adolescents to adulthood.
